Skip to Main Content

Paper Details

Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer.
Cancer
13
2020
LS, Lynch syndrome, MLH1, MLH1 promoter, MLH1-deficient tumors, MMR, MMR deficiency, MMR-deficient tumors, MSH2, MSH6, OC, PMS1, PMS1 homolog 2, PMS2, Tumors, Women, cancer, germline, mismatch repair system, mutL, mutL homolog 1, mutS, mutS homolog 2, mutS homolog 6, nonserous and/or nonmucinous ovarian cancer, ovarian cancer, patients, woman, women
Author NameAffiliation
Raymond H KimUniversity Health Network
Raymond H KimFamilial Gastrointestinal Cancer Registry, Mount Sinai Hospital
Raymond H KimPrincess Margaret Cancer Centre, University Health Network
Blaise A ClarkeUniversity of Toronto
Steven GallingerPrincess Margaret Cancer Centre, University Health Network
Trevor J PughUniversity of Toronto
Trevor J PughPrincess Margaret Cancer Centre, University Health Network
Trevor J PughOntario Institute for Cancer Research, University Health Network
Trevor J PughUniversity of Toronto
Trevor J PughOntario Institute for Cancer Research, University Health Network
Trevor J PughPrincess Margaret Cancer Centre, University Health Network
Aaron PollettUniversity of Toronto
Aaron PollettMount Sinai Hospital
  • 1 - 13

Datasets

Release 1.2